Below is a list of some of the story stocks to watch for April 23, 2011
AstraZeneca (AZN) will buy Ardea Biosciences (RDEA) for $1.26B, giving it access to a new drug for treating gout patients. Net of the existing cash held by Ardea, the $32/share acquisition is valued at $1B and is a 54% premium to Ardea's Friday close.
Top Story Stocks Performance - 4/23/12
Ticker Company Performance
RDEA Ardea Biosciences, Inc. 51.58%
AMLN Amylin Pharmaceuticals, Inc. 11.47%
EAT Brinker International Inc. 9.03%
BKS Barnes & Noble, Inc. 7.76%
FONR Fonar Corp. 5.87%
PHG Koninklijke Philips Electronics NV 3.73%
BEAV BE Aerospace Inc. 3.39%
HLX Helix Energy Solutions Group, Inc. 3.05%
STI SunTrust Banks, Inc. 2.88%
DHI DR Horton Inc. 2.15%
XRX Xerox Corp. 1.65%
UAL United Continental Holdings, Inc. 1.48%
IDIX Idenix Pharmaceuticals Inc. 1.32%
DNDN Dendreon Corp. 1.26%
SNDK SanDisk Corp. 1.23%
GRPN Groupon, Inc. 1.08%
BAS Basic Energy Services, Inc. 1.06%
CAKE The Cheesecake Factory Incorporated 1.04%
GILD Gilead Sciences Inc. 0.71%
LSI LSI Corporation 0.63%
ZION Zions Bancorp. 0.54%
AKAM Akamai Technologies, Inc. 0.49%
CHK Chesapeake Energy Corporation 0.34%
WPI Watson Pharmaceuticals, Inc. 0.27%
KEY KeyCorp 0.25%
GNC GNC Holdings Inc. 0.20%
UNP Union Pacific Corporation 0.08%
NLY Annaly Capital Management, Inc. 0.05%
EC Ecopetrol SA 0.05%
KMB Kimberly-Clark Corporation 0.03%
PHM PulteGroup, Inc. 0.00%
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/